Peter Mathae

General Manager @ Desitin Pharma | CNS & Rare Diseases | P&L Ownership | Strategic Growth & Scale-Up

Zurich, Zurich, Switzerland

About

Experienced senior executive with P&L responsibility, driving strategy and execution in pharma. As General Manager at Desitin Pharma, I lead CNS and Rare Diseases growth, focusing on sustainability, innovation, and patient impact. My key strengths involve scaling businesses, implementing growth strategies, and developing high-performing teams. I blend strategic planning with practical execution and maintain a strong focus on results. Key focus areas: • P&L leadership and business performance • Business scaling and transformation • Market development in CNS and Rare Diseases • Building and leading high-performance teams Open to exchanging ideas on growth strategies, partnerships, and innovation in pharma.

Experience

  • General Manager at Desitin Pharma GmbH
    Dec 2022 - Present · 3 yrs 7 mos

  • Managing Director at Kaper Pharma
    Oct 2018 - Dec 2022 · 4 yrs 3 mos

  • ACINO (3 yrs 6 mos)
    • Head Corporate Commercial Operations
      May 2016 - Sep 2018 · 2 yrs 5 mos

    • Head of Strategy & Portfolio
      Apr 2015 - May 2016 · 1 yr 2 mos

  • Director Portfolio Management at Allergan
    Dec 2011 - Apr 2015 · 3 yrs 5 mos

  • Mepha (3 yrs 1 mo)
    • Head Portfolio Management & Market Development
      Feb 2011 - Nov 2011 · 10 mos

    • International Product Manager
      Nov 2008 - Feb 2011 · 2 yrs 4 mos